Close Menu

NEW YORK – The Foundation for Innovative New Diagnostics announced on Monday that the Canadian government has awarded it C$20 million ($15.7 million) to help expand SARS-CoV-2 testing in low- and middle-income countries (LMIC).

The investment will facilitate the optimization of new rapid diagnostic tests for affordability and ease of use in such territories, FIND said, adding it will also generate evidence for use outside of clinical and laboratory settings and support the implementation of testing in primary care and community settings.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.